Clinical Trial Update: Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports [Phase 3]

View source ↗

Summary

Phase 3 trial updating rivaroxaban for thromboprophylaxis in high-risk cancer patients with totally implantable ports is in progress with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: LiuZhou People's Hospital | Conditions: Rivaroxaban, Thromboprophylaxis | Phase 3 | Status: UNKNOWN